Advertisement

Topics

Global Hospital Acquired Disease Testing Market by Infection Type, Diagnostic Tests, Growth Trends and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.

22:00 EST 3 Mar 2017 | PR.com

Maryland Heights, MO, March 04, 2017 --(PR.com)-- The global hospital acquired disease testing market was valued at USD 564 Million in 2015 and is estimated to reach USD 1.2 Billion by 2020, at a CAGR of 17.5% from 2016 to 2020, due to rising drug resistant pathogens worldwide.

Browse Hospital Acquired Disease Testing Market by Test Type (Blood Stream Associated Infection, MRSA Infection, Hospital-Acquired Pneumonia, Surgical Associated Infection, UTI, Gastroenteritis, Puerperal Fever) 2016-2020 at https://www.ihealthcareanalyst.com/report/hospital-acquired-disease-testing-market/.

Hospital-acquired infection (HAI) or nosocomial infection can be contracted from the environment or staff of a healthcare facility. It can be spread in the hospital environment, nursing home environment, rehabilitation facility, clinic, or other clinical settings. The recent global resurgence of HAIs including discovery of new pathogens, recurrence of old infections and rapid spread of antimicrobial resistant pathogens. Diagnosis of such diseases is essential for prompt and efficient treatment of patients thereby reducing the overall duration of hospital stay, cost of healthcare, patient morbidity and mortality rates. HAIs are considered as a significant cause of death and are acquired while receiving healthcare treatment. Rapid adoption of advanced molecular diagnostics methods, well defined regulatory framework and observation guidelines are the major factors driving the North America hospital acquired disease testing market.

The global hospital acquired disease testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on disease test (blood stream associated infection, MRSA infection, Hospital-acquired pneumonia, surgical associated infection, UTI, Gastroenteritis, puerperal fever, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). The global hospital acquired disease testing market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The global hospital acquired disease testing market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global hospital acquired disease testing market and included in this report are Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche, Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

To request Table of Contents and Sample Pages of this report visit:

https://www.ihealthcareanalyst.com/report/hospital-acquired-disease-testing-market/

About Us

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com

Contact Information:
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
Contact via Email
https://www.ihealthcareanalyst.com/

Read the full story here: http://www.pr.com/press-release/707653

Press Release Distributed by PR.com

Original Article: Global Hospital Acquired Disease Testing Market by Infection Type, Diagnostic Tests, Growth Trends and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.

NEXT ARTICLE

More From BioPortfolio on "Global Hospital Acquired Disease Testing Market by Infection Type, Diagnostic Tests, Growth Trends and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...